PSPriscila Queiroz Mattos da Silva

Priscila Queiroz Mattos da Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Priscila Queiroz Mattos da Silva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Therapeutic challenges of recurrent oral squamous cell carcinomas in fanconi anemia: a case report

    by Camila Adriane Leffa Rosa, Waleska Tychanowicz Kolodziejwski, Priscila Queiroz Mattos da Silva, Angela Maira Guimarães, Juliana Lucena Schussel

    Fanconi anemia (FA) is a rare, inherited recessive syndrome characterized by progressive bone marrow failure and a predisposition to developing malignant neoplasms. A male patient diagnosed with Fanconi anemia underwent a haploidentical hematopoietic cell transplantation (HCT) at 10 years of age. Eleven years later, he developed his first malignant lesion on the lower lip. Unfortunately, the patient experienced rapid recurrences of squamous cell carcinoma (SCC), initially in the oral cavity, with subsequent progression to the maxillary sinus, sphenoid wing, and right orbital floor. The aggressive nature of the disease, coupled with limited treatment options, ultimately led to a poor prognosis and the patient subsequently passed away. This case underscores the severity of Fanconi anemia, demonstrated by the emergence of multiple lesions in diverse locations and their rapid progression in a young patient. It highlights the complexity and significant challenges in managing malignant lesions in patients with FA.

  • Open Access

    Therapeutic challenges of recurrent oral squamous cell carcinomas in fanconi anemia: a case report

    by Camila Adriane Leffa Rosa, Waleska Tychanowicz Kolodziejwski, Priscila Queiroz Mattos da Silva, Angela Maira Guimarães, Juliana Lucena Schussel

    Fanconi anemia (FA) is a rare, inherited recessive syndrome characterized by progressive bone marrow failure and a predisposition to developing malignant neoplasms. A male patient diagnosed with Fanconi anemia underwent a haploidentical hematopoietic cell transplantation (HCT) at 10 years of age. Eleven years later, he developed his first malignant lesion on the lower lip. Unfortunately, the patient experienced rapid recurrences of squamous cell carcinoma (SCC), initially in the oral cavity, with subsequent progression to the maxillary sinus, sphenoid wing, and right orbital floor. The aggressive nature of the disease, coupled with limited treatment options, ultimately led to a poor prognosis and the patient subsequently passed away. This case underscores the severity of Fanconi anemia, demonstrated by the emergence of multiple lesions in diverse locations and their rapid progression in a young patient. It highlights the complexity and significant challenges in managing malignant lesions in patients with FA.

  • Open Access

    IL17A and IL17RA gene polymorphisms in Fanconi anemia

    by Rafael Zancan Mobile, Monalisa Castilho Mendes, Cleber Machado-Souza, Priscila de Mattos Queiroz, Carmem Maria Sales Bonfim, Cassius Carvalho Torres-Pereira, Juliana Lucena Schussel

    Fanconi anemia is a rare autosomal recessive disease. In this disease, cytokine pathways can induce the bone marrow failure that is observed in individuals with Fanconi anemia. Interleukin IL-17 exhibits a protective effect in organisms because it induces neutrophil recruitment and shows a pathological role in several models of autoimmune diseases, periodontal disease, cancer, allograft rejection, and graft versus host disease. Polymorphisms in the IL17A and IL17RA genes were evaluated from DNA in saliva, comparing individuals with or without Fanconi anemia, using models of genotypic transmission (additive, dominant, and recessive). Polymorphisms in the IL17A and IL17RA genes (rs2241044 [C allele], rs879577 [C allele], rs9606615 [T allele], and rs2241043 [C allele]) were risk factors for developing Fanconi anemia. We also performed an analysis of gene markers with clinical variables in the Fanconi group. Polymorphisms in the IL17A gene (rs3819025 [A allele] and rs2275913 [G allele], respectively) were associated with an age of less than 20 years (p = 0.026; RP 0.65) and the female sex (p = 0.043; RP 0.88). The IL17RA gene was also associated with age and the presence of leukoplakia (a potentially malignant oral disorder). An age of less than 20 years was associated with rs917864 (T allele; p = 0.036; RP 0.67). The presence of leukoplakia was associated with rs17606615 (T allele; p = 0.042; RP 0.47). To our knowledge, this is the first study that associates IL17A and IL17RA gene polymorphisms with Fanconi anemia and examines rs2241044 polymorphisms in scientific literature thus far.